Chinese Journal of Blood Purification ›› 2023, Vol. 22 ›› Issue (07): 481-483.doi: 10.3969/j.issn.1671-4091.2023.07.001

    Next Articles

Consideration of the supervision of hemoperfusion device

ZHAN Na, ZOU Yan-guo, LI Dan, QIANG Yi-ning, ZENG Zhu   

  1. Center for Medical Device Evaluation, NMPA, Beijing 100081, China; 2Yangtze River Delta Branch Center for Medical Device Evaluation and inspection of National Medical Products Administration, Shanghai 200120, China; 3Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430022, China
  • Received:2023-03-27 Revised:2023-05-06 Online:2023-07-12 Published:2023-07-12
  • Contact: 100081 北京,1国家药品监督管理总局医疗器械技术审评中心 E-mail:kay20014098@sohu.com

Abstract: Hemoperfusion device is widely used in the treatment of renal failure, liver failure, poisoning, autoimmune diseases, et al. This article tends to introduce the common registration problems and difficulties of these hemoperfusion devices from the perspective of medical device registration supervision.

CLC Number: